The Phase 2 trial is not definitive, but it comes as vaccine access is severely restricted.
Daily squirts of a safe, over-the-counter allergy nasal spray may prevent COVID-19 infections from taking hold, according to results published Tuesday in JAMA Internal Medicine. In a mid-staged trial, the spray appeared to reduce infections by promis... [2138 chars]